SGL
ADVM

Sonic GP LLC’s Adverum Biotechnologies ADVM Stock Holding History

Sonic GP LLC’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200,000
Closed -$1.51M – 16
2023
Q4 		$1.51M Hold
200,000
– – 1.73% 11
2023
Q3 		$3M Hold
200,000
– – 2.91% 13
2023
Q2 		$3.18M Hold
200,000
– – 2.12% 17
2023
Q1 		$1.43M Sell
200,000
-255,207
-56% -$1.8M 1.1% 20
2022
Q4 		$2.64M Buy
+455,207
New +$3.45M 1.98% 17

Other funds holding ADVM

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Sonic GP LLC's ADVM Position: Q1 2024 in Review

Sonic GP LLC sold out of Adverum Biotechnologies (ADVM) in Q1 2024, closing a stake of 200,000 shares — an estimated $1.51M sold.

Sonic GP LLC first reported a position in ADVM in Q4 2022 and held it in 5 quarters. The position peaked at $3.18M in Q2 2023. 61 funds tracked by Wall St. Rank hold ADVM as of Q1 2024.

  • Sonic GP LLC reported no remaining Adverum Biotechnologies position as of Q1 2024 after selling out during the quarter.
  • Sonic GP LLC sold 200,000 Adverum Biotechnologies shares in Q1 2024, an estimated $1.51M.
  • Sonic GP LLC first reported a position in Adverum Biotechnologies in Q4 2022 and held it in 5 quarters.
  • Sonic GP LLC's Adverum Biotechnologies position peaked at $3.18M in Q2 2023.
  • 61 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2024.

Based on Sonic GP LLC's 13F filing for Q1 2024, filed 15 May 2024.